"Lipopolysaccharides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)
| Descriptor ID |
D008070
|
| MeSH Number(s) |
D09.400.500 D09.698.718.450 D10.494 D23.050.161.616.525 D23.946.123.329.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharides".
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharides".
This graph shows the total number of publications written about "Lipopolysaccharides" by people in this website by year, and whether "Lipopolysaccharides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 1 | 4 | 5 |
| 2000 | 2 | 3 | 5 |
| 2001 | 0 | 5 | 5 |
| 2002 | 2 | 9 | 11 |
| 2003 | 4 | 1 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 6 | 10 |
| 2006 | 3 | 9 | 12 |
| 2007 | 0 | 11 | 11 |
| 2008 | 5 | 5 | 10 |
| 2009 | 3 | 9 | 12 |
| 2010 | 0 | 4 | 4 |
| 2011 | 3 | 7 | 10 |
| 2012 | 2 | 7 | 9 |
| 2013 | 0 | 7 | 7 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 6 | 7 |
| 2016 | 4 | 8 | 12 |
| 2017 | 1 | 5 | 6 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 5 | 7 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 7 | 7 |
| 2023 | 2 | 6 | 8 |
| 2024 | 5 | 4 | 9 |
| 2025 | 4 | 4 | 8 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipopolysaccharides" by people in Profiles.
-
Inflammatory Preconditioning Reprograms Mesenchymal Stromal Cell-Derived Extracellular Vesicles into Distinct Functional States for Immunomodulation and Wound Healing. Stem Cells Dev. 2026 Jul; 35(13-14):247-262.
-
Fibrinogen and lipopolysaccharide promote TLR4-dependent glucocorticoid resistance in airway mycosis-driven allergic airway disease. Mucosal Immunol. 2026 Aug; 19(4):100354.
-
Time-restricted feeding in adult mice improves mood-related behaviors in a sex-dependent manner. Behav Brain Res. 2026 01 05; 496:115867.
-
Dietary lipids induce PPARd and BCL6 to repress macrophage IL-23 induction after intestinal injury and LPS exposure. Sci Rep. 2025 Jul 27; 15(1):27344.
-
Exogenous arginine differentially regulates inflammatory cytokine and inducible nitric oxide synthase expression in macrophages. Immunohorizons. 2025 07 14; 9(8).
-
Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. Cochrane Database Syst Rev. 2025 06 11; 6:CD016071.
-
Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV. Cochrane Database Syst Rev. 2025 06 10; 6:CD016070.
-
Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study. Lancet Microbe. 2025 Jul; 6(7):101085.
-
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis. Tuberculosis (Edinb). 2025 May; 152:102619.
-
Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens. mBio. 2025 02 05; 16(2):e0341224.